MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 218 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,982,000 | +57.4% | 98,041 | +34.3% | 0.73% | +89.3% |
| Q1 2022 | $1,895,000 | -36.4% | 73,008 | -50.0% | 0.38% | +25.9% |
| Q4 2021 | $2,978,000 | +112.0% | 146,016 | +100.0% | 0.30% | -0.7% |
| Q3 2021 | $1,405,000 | -65.9% | 73,008 | -60.7% | 0.31% | -58.6% |
| Q2 2021 | $4,124,000 | -1.0% | 185,939 | +17.2% | 0.74% | -2.4% |
| Q1 2021 | $4,165,000 | +40.5% | 158,664 | 0.0% | 0.76% | +20.1% |
| Q4 2020 | $2,965,000 | +14.8% | 158,664 | +4.3% | 0.63% | -7.6% |
| Q3 2020 | $2,583,000 | -21.2% | 152,140 | +8.0% | 0.68% | -17.8% |
| Q2 2020 | $3,280,000 | +395.5% | 140,820 | +78.6% | 0.83% | +309.9% |
| Q1 2020 | $662,000 | – | 78,859 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |